3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Surgical Wound Infection
4
Neoplasms
4
Colorectal Neoplasms
3
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Sepsis
1
Pancreatic Fistula
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Intestinal Neoplasms
1
Inflammation
1
Infections
1
Hematologic Neoplasms
1
Glioblastoma
1
Fever
1
Febrile Neutropenia
1
Exanthema
1
Emergencies
1
Duodenal Neoplasms
1
Discitis
1
Interventions
telavancin
1
soybean oil, phospholipid emulsion
1
drotrecogin alfa activated
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
Simvastatin
1
Saline Solution
1
Povidone-Iodine
1
Methods
1
Meropenem
1
Massage
1
Levofloxacin
1
Hydrochloric Acid
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gentamicins
1
Colistin
1
Colchicine
1
ClinOleic
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Alkaline Phosphatase
1
Acupuncture Therapy
1
2-Propanol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sepsis
×
Anti-Bacterial Agents
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled